New Haven Pharmaceuticals Lands $6,490,773 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94c34e1b-d328-41b8-b695-74d887e572db&Preview=1
Date
10/4/2012
Company Name
New Haven Pharmaceuticals
Mailing Address
142 Temple Street New Haven, CT 06510
Company Description
New Haven Pharmaceuticals, Inc. (NHP) develops proprietary, controlled release specialty pharmaceuticals based on approved or GRAS active pharmaceutical ingredients for use in new therapeutic indications. NHP’s novel product pipeline is built on three licenses from Yale University and Micropump Aspirin, the world’s only 24-hour controlled-release aspirin, licensed from Flamel Technologies.
Website
http://www.newhavenpharma.com
Transaction Type
Venture Equity
Transaction Amount
$6,490,773
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed